EverSource Wealth Advisors LLC boosted its stake in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 36.7% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 14,632 shares of the company’s stock after purchasing an additional 3,932 shares during the period. EverSource Wealth Advisors LLC’s holdings in Procter & Gamble were worth $2,352,000 at the end of the most recent reporting period.
A number of other hedge funds also recently made changes to their positions in the stock. Itau Unibanco Holding S.A. acquired a new stake in Procter & Gamble during the 2nd quarter worth approximately $28,000. Fairway Wealth LLC acquired a new position in Procter & Gamble during the second quarter valued at approximately $29,000. Ruedi Wealth Management Inc. grew its stake in Procter & Gamble by 64.7% during the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after buying an additional 77 shares during the period. POM Investment Strategies LLC acquired a new stake in shares of Procter & Gamble in the second quarter worth $34,000. Finally, Transcendent Capital Group LLC purchased a new position in shares of Procter & Gamble in the 4th quarter valued at $31,000. Institutional investors and hedge funds own 65.77% of the company’s stock.
Insider Buying and Selling
In related news, CFO Andre Schulten sold 13,041 shares of the company’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the completion of the transaction, the chief financial officer now directly owns 37,208 shares in the company, valued at approximately $6,325,360. The sale was disclosed in a document filed with the SEC, which is available through this link. In other news, CFO Andre Schulten sold 13,041 shares of the company’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the completion of the transaction, the chief financial officer now owns 37,208 shares in the company, valued at $6,325,360. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Balaji Purushothaman sold 8,842 shares of Procter & Gamble stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the completion of the sale, the insider now owns 11,537 shares in the company, valued at $1,902,451.30. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 375,553 shares of company stock valued at $63,829,141. Insiders own 0.17% of the company’s stock.
Procter & Gamble Price Performance
Procter & Gamble (NYSE:PG – Get Free Report) last issued its earnings results on Tuesday, July 30th. The company reported $1.40 earnings per share for the quarter, topping analysts’ consensus estimates of $1.37 by $0.03. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The company had revenue of $20.53 billion for the quarter, compared to analysts’ expectations of $20.69 billion. During the same period in the prior year, the company earned $1.37 earnings per share. The firm’s revenue was down .1% compared to the same quarter last year. As a group, equities research analysts expect that The Procter & Gamble Company will post 6.97 earnings per share for the current year.
Procter & Gamble Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Friday, July 19th were issued a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a dividend yield of 2.31%. The ex-dividend date of this dividend was Friday, July 19th. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.69%.
Analysts Set New Price Targets
PG has been the subject of a number of research reports. BNP Paribas initiated coverage on shares of Procter & Gamble in a research report on Monday, June 24th. They set an “outperform” rating and a $187.00 price target for the company. DZ Bank upgraded Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 target price for the company in a research note on Thursday, August 29th. Jefferies Financial Group downgraded Procter & Gamble from a “buy” rating to a “hold” rating and dropped their target price for the company from $182.00 to $175.00 in a report on Wednesday, July 24th. Stifel Nicolaus upped their price target on Procter & Gamble from $157.00 to $161.00 and gave the stock a “hold” rating in a report on Monday, July 22nd. Finally, StockNews.com lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Seven research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, Procter & Gamble currently has a consensus rating of “Moderate Buy” and an average price target of $176.00.
View Our Latest Stock Report on PG
Procter & Gamble Company Profile
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.
Read More
- Five stocks we like better than Procter & Gamble
- What Investors Need to Know to Beat the Market
- 3 Stocks That Could Rise on European Bank Interest Rate Cuts
- Best Stocks Under $10.00
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- How to Invest in Biotech Stocks
- MarketBeat Week in Review – 9/16 – 9/20
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.